XML 143 R35.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of Components of Income (Loss) Before Provision for Income Tax

The Company has operations in the United States and Canada. The components of income (loss) before the provision for income taxes are as follows (in thousands):

 

   2023   2022 
   For the year ended December 31, 
   2023   2022 
United States  $(33,827)  $(30,456)
Foreign   65    22 
Total loss before income taxes  $(33,762)  $(30,434)
Schedule of Income Tax Provision

The components of the income tax provision for the years ended December 31, 2023 and 2022 were as follows (in thousands):

 

   2023   2022 
   As of December 31, 
   2023   2022 
Current federal  $-   $- 
Current state   -    - 
Current foreign   18    17 
Total current tax provision (benefit)  $18   $17 
Deferred federal   -    - 
Deferred state   -    - 
Deferred foreign   -    - 
Total deferred tax provision (benefit)  $-   $- 
Total income tax provision (benefit)  $18   $17 
Schedule of Reconciliation of Income Tax Benefit

A reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate is as follows:

 

   2023   2022 
   As of December 31, 
   2023   2022 
Tax provision at statutory rate   21.0%   21.0%
State taxes, net of federal benefit   0.2%   (1.2)%
Stock-based compensation expense   (0.9)%   (1.4)%
Permanent differences - other   (0.2)%   0.0%
Change in fair value of convertible notes   (11.0)%   (10.5)%
Change in fair value of warrants   (5.7)%   (5.8)%
Change in valuation allowance   (3.4)%   (1.0)%
Other, net   (0.1)%   (1.2)%
Effective income tax rate   -0.1%   -0.1%
Schedule of Components of Deferred Tax Assets and Liabilities

The tax effects of temporary differences that give rise to significant components of the deferred tax assets and liabilities are as follows (in thousands):

 

   2023   2022 
   As of December 31, 
   2023   2022 
Deferred tax assets          
Net operating loss carryforwards  $7,393   $6,551 
Capitalized research costs   337    - 
Fixed assets   25    34 
Other   4    16 
Total gross deferred tax assets   7,759    6,601 
Less: valuation allowance   (7,753)   (6,597)
Net deferred tax assets  $6   $4 
Deferred tax liabilities          
Other  $(6)  $(4)
Total deferred tax liabilities  $(6)  $(4)
Net deferred taxes  $-   $-